Last CNY18.30 CNY
Change Today +0.80 / 4.57%
Volume 13.5M
002020 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

zhejiang jingxin pharmaceu-a (002020) Snapshot

Open
CNY18.23
Previous Close
CNY17.50
Day High
CNY18.48
Day Low
CNY17.82
52 Week High
03/7/14 - CNY18.81
52 Week Low
06/25/13 - CNY8.55
Market Cap
4.6B
Average Volume 10 Days
4.5M
EPS TTM
CNY0.28
Shares Outstanding
252.7M
EX-Date
--
P/E TM
65.1x
Dividend
CNY0.10
Dividend Yield
0.41%
Current Stock Chart for ZHEJIANG JINGXIN PHARMACEU-A (002020)

Related News

No related news articles were found.

zhejiang jingxin pharmaceu-a (002020) Related Businessweek News

No Related Businessweek News Found

zhejiang jingxin pharmaceu-a (002020) Details

Zhejiang Jingxin Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of finished dosage forms and API’s in the People’s Republic of China. The company focuses on novelty and generic drugs for anti-infective, cardiovascular, and cerebrovascular diseases, such as hypertension, hyperlipemia, hyperglycemia, and antiplatelet coagulating; and central nervous system drugs, including antidepressant, antipsychotic, antiparkinsonian, anti-alzheimer's disease, sedative-hypnotic, and anticonvulsant. The company’s finished dosage forms include tablets, capsules, and powders for injections in the areas of antilipemic, antidiabetic, antihypertensive, gastrointestinal promotion, antihistamine, cerebrovarscular, quitting smoking assistant, anti-inflammatory analgesic, and antibiotics. It also provides Chinese herbal drugs. The company exports its products to south-east Asia, south Asia, Latin America, and Europe. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1974 and is headquartered in Xinchang, the People’s Republic of China.

Founded in 1974

zhejiang jingxin pharmaceu-a (002020) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang jingxin pharmaceu-a (002020) Key Developments

Zhejiang Jingxin Pharmaceutical Co., Ltd., Annual General Meeting, Mar 25, 2014

Zhejiang Jingxin Pharmaceutical Co., Ltd., Annual General Meeting, Mar 25, 2014., at 14:00 China Standard Time. Agenda: To consider 2013 work report of the board of directors; to consider 2013 work report of the supervisory committee; to consider 2013 annual report and its summary; to consider 2013 profit distribution plan of CNY 1.0 per 10 shares (tax included); to consider 2013 financial resolution report; to consider reappointment of audit firm; to consider guarantee for wholly-owned subsidiaries; and to consider to continue to temporarily replenish working capital with partial idle raised funds.

Zhejiang Jingxin Pharmaceutical Propose Profit Distribution Plan of 2013

Zhejiang Jingxin Pharmaceutical will hold its AGM on March 25, 2014, to propose profit distribution plan of 2013 as cash dividend per 10 shares (tax included) of CNY 1.00.

Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report Fiscal Year 2013 Final Results on Mar 04, 2014

Zhejiang Jingxin Pharmaceutical Co., Ltd. announced that they will report fiscal year 2013 final results on Mar 04, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002020:CH CNY18.30 CNY +0.80

002020 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002020.
View Industry Companies
 

Industry Analysis

002020

Industry Average

Valuation 002020 Industry Range
Price/Earnings 69.9x
Price/Sales 4.6x
Price/Book 5.5x
Price/Cash Flow 69.9x
TEV/Sales 4.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG JINGXIN PHARMACEU-A, please visit www.jingxinpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.